Using advanced imaging methods, researchers have gained insight into how a common target of drugs sends cellular signals, a finding that may lead to better and more precise therapeutics.
One of the most important molecules in the brain doesn’t work quite the way scientists thought it did, according to new work by researchers at Columbia and Carnegie Mellon.
What is cannabis good for? Columbia’s cannabis research director explains cannabinoids, CBD, THC, cannabis use disorder, potential therapeutic uses of marijuana, and more.
Columbia University's new "COVID-19 Trial Finder" is a simplified method for patients, clinicians, and healthy volunteers to find appropriate COVID clinical trials near their home.
The fluctuations of gut microbial communities follow ecological principles developed for animals and financial markets, which may help to predict disease biomarkers and effects of unhealthy diets.
Based on the book by Columbia oncologist Siddhartha Mukherjee, the documentary also features Wendy Chung, David Goldstein, Samuel Sternberg, and Nancy Wexler. The two-part series airs April 7 and 14.
Data scientists from Columbia University and around the world are starting to use the world’s electronic health records and databases to identify the best therapies for treating COVID-19 patients.
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus.
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.
Non-medical cannabis use—including frequent or problematic use—is more common in adults with pain than in those without pain, a new study from Columbia University has found.
Some compounds found in many personal care products displace natural fat-like molecules in skin cells, which may explain how they cause an allergic skin rash.